Submission Details
| 510(k) Number | K181166 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 02, 2018 |
| Decision Date | July 18, 2019 |
| Days to Decision | 442 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K181166 is an FDA 510(k) clearance for the Trilogy Evo, a Ventilator, Continuous, Facility Use (Class II — Special Controls, product code CBK), submitted by Respironics, Inc. (Murrysville, US). The FDA issued a Cleared decision on July 18, 2019, 442 days after receiving the submission on May 2, 2018. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.5895.
| 510(k) Number | K181166 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 02, 2018 |
| Decision Date | July 18, 2019 |
| Days to Decision | 442 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | CBK — Ventilator, Continuous, Facility Use |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.5895 |